Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.66 |
| ▸ | MAPT | P10636 | 3/20 | 0.66 |
| ▸ | BLM | P54132 | 3/20 | 0.66 |
| ▸ | LMNA | P02545 | 2/20 | 0.66 |
| ▸ | TSHR | P16473 | 2/20 | 0.66 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.66 |
| ▸ | MEN1 | O00255 | 2/20 | 0.66 |
| ▸ | MPO | P05164 | 1/20 | 0.66 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.66 |
| ▸ | PTPRA | P18433 | 1/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | HTR2A | P28223 | 2/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | HTR1A | P08908 | 1/20 | 0.61 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL503548 | 1.00 | KMT2A (0.66) | KMT2AKDM4EMAPTBLMLMNA | |
| SCHEMBL29809822 | 1.00 | KMT2A (0.66) | KMT2AKDM4EMAPTBLMLMNA | |
| SCHEMBL31036029 | 1.00 | KMT2A (0.66) | KMT2AKDM4EMAPTBLMLMNA | |
| SCHEMBL503549 | 1.00 | KMT2A (0.66) | KMT2AKDM4EMAPTBLMLMNA | |
| SCHEMBL24113516 | 0.89 | SCN9A (0.59) | KMT2AKDM4EMAPTBLMLMNA | |
| SCHEMBL41266 | 0.89 | KMT2A (0.73) | KMT2AKDM4EMAPTBLMLMNA | |
| SCHEMBL30310502 | 0.89 | SCN9A (0.59) | KMT2AKDM4EMAPTBLMLMNA | |
| SCHEMBL16975865 | 0.89 | HTR2A (0.55) | KMT2AKDM4EMAPTBLMLMNA | |
| SCHEMBL41267 | 0.89 | KMT2A (0.73) | KMT2AKDM4EMAPTBLMLMNA | |
| SCHEMBL29527694 | 0.89 | KMT2A (0.73) | KMT2AKDM4EMAPTBLMLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | claimed |
| US-20250222146-A1 | Radiopharmaceuticals Targeting Somatostatin Receptor 2 and Uses Thereof | RAYZEBIO, INC. (US) | 2025-07-10 | — | — | US | disclosed |
| WO-2025137443-A1 | RADIOPHARMACEUTICAL COMPOSITIONS TARGETING SOMATOSTATIN RECEPTORS AND USES THEREOF | RAYZEBIO, INC. (US) | 2025-06-26 | — | — | WO | disclosed |
| WO-2025137441-A1 | RADIOPHARMACEUTICALS TARGETING SOMATOSTATIN RECEPTOR 2 AND USES THEREOF | RAYZEBIO, INC. (US) | 2025-06-26 | — | — | WO | disclosed |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | disclosed |
| CN-113861097-A | Synthesis method of multi-configuration 1-Boc-N-Fmoc tryptophan compound | 苏州爱玛特生物科技有限公司 | 2021-12-31 | — | — | CN | disclosed |
| EP-0443923-B1 | New aminophosphine-phosphinites, their process and their use for enantio-selective reactions | SANOFI SA (FR) | 1997-08-27 | — | — | EP | disclosed |
| US-5210202-A | Chiral phosphorous compounds, a process for their manufacture and their application to the catalysis of enantioselective synthesis reactions | SOCIETE CHIMIQUE DES CHARBONNAGES S.A. (FR) | 1993-05-11 | — | — | US | disclosed |
| US-5099077-A | Dihydrocarbylphosphioxy substituted groups with amine or phosphinoamines as ligands | SOCIETE CHIMIQUE DES CHARBONNAGES S.A. (FR) | 1992-03-24 | — | — | US | disclosed |
| EP-0443923-A1 | New aminophosphine-phosphinites, their process and their use for enantio-selective reactions | SANOFI (FR) | 1991-08-28 | — | — | EP | disclosed |
| US-4877908-A | Chiral phosphorus compounds, a process for their manufacture and their application to the catalysis of enantioselective synthesis reactions | NORSOLOR (FR) | 1989-10-31 | — | — | US | disclosed |
| EP-0136210-B1 | CHIRAL PHOSPHORUS LIGANDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN THE CATALYSIS OF ENANTIOSELECTIVE SYNTHESIS REACTIONS | NORSOLOR S.A. (FR) | 1989-08-16 | — | — | EP | disclosed |
| EP-0136210-A1 | Chiral phosphorus ligands, process for their preparation and their use in the catalysis of enantioselective synthesis reactions | NORSOLOR S.A. (FR) | 1985-04-03 | — | — | EP | disclosed |
| US-4316847-A | ARTIFICIAL SWEETENING | HOFFMANN-LA ROCHE INC. (US) | 1982-02-23 | — | — | US | disclosed |
| US-4256641-A | ALKYL ALPHA-CARBOXAMIDOINDOLE-3-ACRYLATES MADE FROM 3-INDOLECARBOXALDEHYDES AND MONOALKYL CARBOXAMIDOMALONATES | HOFFMANN-LA ROCHE INC. (US) | 1981-03-17 | — | — | US | disclosed |
| US-4140697-A | ARTIFICIAL SWEETENER | HOFFMANN-LA ROCHE INC. (US) | 1979-02-20 | — | — | US | disclosed |
| US-4073795-A | Synthesis of tryptophans | HOFFMANN-LA ROCHE INC. (US) | 1978-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250222146-A1 | Radiopharmaceuticals Targeting Somatostatin Receptor 2 and Uses Thereof | SSTR2, SSTR4, SSTR5 | KMT2A 1730/4885KDM4E 3869/4885MAPT 3475/4885 |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | BCAT1, BCAT2, PELP1 | KMT2A 3415/4885KDM4E 3586/4885MAPT 1809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.